Evidence map›Paper›PMID 30760604›Full record

ArticleOccupational and environmental medicine2019

Case-control investigation of occupational lead exposure and kidney cancer.

Catherine L Callahan, Melissa C Friesen, Sarah J Locke, Pamela J Dopart, Patricia A Stewart, Kendra Schwartz, Julie J Ruterbusch, Barry I Graubard, Wong-Ho Chow, Nathaniel Rothman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Occupational and environmental medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Catherine L CallahanOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Melissa C FriesenOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Sarah J LockeOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Pamela J DopartOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Patricia A StewartStewart Exposure Assessments, LLC, Arlington, Texas, USA.
Kendra SchwartzDepartment of Family Medicine and Public Health Sciences, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Julie J RuterbuschDepartment of Family Medicine and Public Health Sciences, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA.
Barry I GraubardBiostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Wong-Ho ChowDepartment of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nathaniel RothmanOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Jonathan N HofmannOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Mark P PurdueOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology Genetics, National Cancer Institute, Bethesda, Maryland, USA.
National Cancer Institute · USDivision of Cancer Epidemiology and GeneticsWayne State University · USOAI Consulting (United States) · USThe University of Texas MD Anderson Cancer Center · US

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

objectivesLead is a suspected carcinogen that has been inconsistently associated with kidney cancer. To clarify this relationship, we conducted an analysis of occupational lead exposure within a population-based study of kidney cancer using detailed exposure assessment methods.

methodsStudy participants (1217 cases and 1235 controls), enrolled between 2002 and 2007, provided information on their occupational histories and, for selected lead-related occupations, answered questions regarding workplace tasks, and use of protective equipment. Industrial hygienists used this information to develop several estimates of occupational lead exposure, including probability, duration and cumulative exposure. Unconditional logistic regression was used to compute ORs and 95% CIs for different exposure metrics, with unexposed subjects serving as the reference group. Analyses were also conducted stratifying on several factors, including for subjects of European ancestry only, single nucleotide polymorphisms in

resultsIn our study, cumulative occupational lead exposure was not associated with kidney cancer (OR 0.9, 95% CI 0.7 to 1.3 for highest quartile vs unexposed; p

conclusionsThe findings of this study do not offer clear support for an association between occupational lead exposure and kidney cancer.

Indexed as

AdultAgedCase-Control StudiesChicagoFemaleHumansKidney NeoplasmsLeadMaleMichiganMiddle AgedOccupational ExposurePersonal Protective EquipmentPolymorphism, Single NucleotidePorphobilinogen SynthaseRisk FactorsLeadPorphobilinogen Synthasecancer epidemiologykidney canceroccupational lead exposure

Identifiers

PMID30760604
PMCPMC10364141
OpenAlexW2913461159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.